Cargando…
Potential of polylactic-co-glycolic acid (PLGA) for delivery Jembrana disease DNA vaccine Model (pEGFP-C1-tat)
BACKGROUND: The development of a vaccine for Jembrana disease is needed to prevent losses in Indonesia's Bali cattle industry. A DNA vaccine model (pEGFP-C1-tat) that requires a functional delivery system will be developed. Polylactic-co-glycolic acid (PLGA) may have potential as a delivery sys...
Autores principales: | Unsunnidhal, Lalu, Wasito, Raden, Nugraha Setyawan, Erif Maha, Warsani, Ziana, Kusumawati, Asmarani |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Veterinary Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636661/ https://www.ncbi.nlm.nih.gov/pubmed/34697922 http://dx.doi.org/10.4142/jvs.2021.22.e76 |
Ejemplares similares
-
In Vitro Evaluation of Chitosan-DNA Plasmid Complex Encoding Jembrana Disease Virus Env-TM Protein as a Vaccine Candidate
por: Ishak, Januar, et al.
Publicado: (2019) -
Expression and epitope prediction of MPT64 recombinant proteins from clinical isolates of Mycobacterium tuberculosis as immunoserodiagnostic candidates
por: Fihiruddin, Fihiruddin, et al.
Publicado: (2022) -
Construction of recombinant pEGFP-N1-hPer2 plasmid and its expression in osteosarcoma cells
por: CHENG, ANYUAN, et al.
Publicado: (2016) -
Co-self-assembly of cationic microparticles to deliver pEGFP-ZNF580 for promoting the transfection and migration of endothelial cells
por: Feng, Yakai, et al.
Publicado: (2016) -
The sustained-release behavior and in vitro and in vivo transfection of pEGFP-loaded core-shell-structured chitosan-based composite particles
por: Wang, Yun, et al.
Publicado: (2014)